184 related articles for article (PubMed ID: 22449006)
21. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
23. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
[TBL] [Abstract][Full Text] [Related]
24. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
26. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
[TBL] [Abstract][Full Text] [Related]
27. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
[TBL] [Abstract][Full Text] [Related]
28. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
[TBL] [Abstract][Full Text] [Related]
30. A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies.
Khanapurmath N; Kulkarni MV; Joshi SD; Anil Kumar GN
Bioorg Med Chem; 2019 Oct; 27(20):115054. PubMed ID: 31471101
[TBL] [Abstract][Full Text] [Related]
31. Thiophene containing triarylmethanes as antitubercular agents.
Parai MK; Panda G; Chaturvedi V; Manju YK; Sinha S
Bioorg Med Chem Lett; 2008 Jan; 18(1):289-92. PubMed ID: 17997304
[TBL] [Abstract][Full Text] [Related]
32. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.
Ramprasad J; Kumar Sthalam V; Linga Murthy Thampunuri R; Bhukya S; Ummanni R; Balasubramanian S; Pabbaraja S
Bioorg Med Chem Lett; 2019 Oct; 29(20):126671. PubMed ID: 31526604
[TBL] [Abstract][Full Text] [Related]
34. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
35. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
36. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S
Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
Lu X; Wan B; Franzblau SG; You Q
Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
[TBL] [Abstract][Full Text] [Related]
38. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2013 Oct; 23(19):5393-6. PubMed ID: 23953191
[TBL] [Abstract][Full Text] [Related]
40. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]